Pušenje svakog biljnog materijala može utjecati na disanje. Pušenje čistog kanabisa čak marginalno povećava kapicitet pluća i razne studije nisu pokazale nikakve značajne razlike između pušača kababisa i nepušača. Dakle pušenje čistog kanabisa ne utječe bitno na dišni sustav. Ako se miješa s duhanom, to je druga priča.
Što se tiče drugih štetnosti, pojavila se nova studija koja navodi da ekstremno jake sorte kanabisa koje su produkt intenzivne hibridizacije mogu utjecati na promjene bijele tvari u mozgu što nije dobro. To se ne događa s nehibridiziranim kanabisom koji ima manji postotak THC-a nego novi hibridi.
Više o tome možeš pročitati na ovom linku:
http://www.sciencedaily.com/releases/2015/11/151127102333.htm
Dolazimo opet do toga da je bitno znati UPOTREBLJAVATI kanabis, a ne ZLOUPOTREBLJAVATI. Kao sa svakom drogom, bitna je doza. Use it, don't abuse it.
Kanabinoidni sustav kao i tolerancija na kanabis se može naglo povećati i naglo smanjiti što znači da se kanabinoidni sustav vrlo brzo popravlja i stoga ne nastaje generalna šteta osim ukoliko se u konzumaciji pretjeruje. To vrijedi za svaki lijek i svaki otrov. Doza čini lijek i doza čini otrov.
Što se tiče samog pušenja kanabisa, dolje ima mnogo referenci što se tiče pušenja kanabisa pa ako želiš pročitaj.
Svega previše može biti štetno, previše šećera ostat ćeš bez zubiju, možeš doboti dijabetes, od previše soli problemi s bubrezima. Tijelo pak treba šećer i sol više nego kabis radi energije, elektrolita i bitniji su za funkcioniranje tijela nego kanabis.
Zaključak ovog posta da kanabis može biti štetan ako se zloupotrebljava i ako su doze previsoke, umjerena konzumacija manje hibridiziranih sorti nemaštetnost, već nasuprot, može pomoći u mnogo toga.
boz
References
- Tan C, Hatam N, Treasure T. Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link. J. R. Soc. Med. 99(2), 77–80 (2006).
- Tan WC, Lo C, Jong A et al. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ 180(8), 814–820 (2009).
- Hall W, Pacula R. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge University Press, Cambridge, UK (2003).
- Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a US sample. J. Gen. Intern. Med. 20(1), 33–37 (2005).
- Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 374, 1383–1391 (2009).
- Poulton RG, Brooke M, Moffitt TE, Stanton WR, Silva PA. Prevalence and correlates of cannabis use and dependence in young New Zealanders. NZ Med. J. 110(1039), 68–70 (1997).
- Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N. Engl. J. Med. 318(6), 347–351 (1988).
- Tashkin DP, Gliederer F, Rose J et al. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and δ-9-THC. Pharmacol. Biochem. Behav. 40, 651–656 (1991).
- Fligiel SEG, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 112(2), 319–326 (1997).
- Aldington S, Williams M, Nowitz M et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 62(12), 1058–1063 (2007).
- Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am. J. Resp. Crit. Care Med. 157, 928–937 (1998).
- Hancox RJ, Poulton R, Ely M et al. Effects of cannabis on lung function: a population-based cohort study. Eur. Resp. J. 35(1), 42–47 (2009).
- Taylor DR, Hall W. Respiratory health effects of cannabis: position statement of the thoracic society of Australia and New Zealand. Intern. Med. J. 33, 310–313 (2003).
- Tashkin DP, Coulson AH, Clark VA et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am. Rev. Respir. Dis. 135(1), 209–216 (1987).
- Sherrill DL, Krzyzanowski M, Bloom JW, Lebowitz MD. Respiratory effects of non-tobacco cigarettes: a longitudinal study in general population. Int. J. Epidemiol. 20(1), 132–137 (1991).
- Polen M, Sidney S, Tekawa I, Sadler M, Friedman G. Healthcare use by frequent marijuana smokers who do not smoke tobacco. Western J. Med. 158, 596–601 (1993).
- Tashkin DP, Simmons MS, Sherrill DL, Coulson AH. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am. J. Resp. Crit. Care Med. 155, 141–148 (1997).
- Tilles DS, Goldenheim PD, Johnson DC, Mendelson JH, Mello NK, Hales CA. Marijuana smoking as cause of reduction in single-breath carbon monoxide diffusing capacity. Am. J. Med. 80(4), 601–606 (1986).
- Bloom J, Kaltenborn W, Paoletti P, Camilli A, Lebowitz M. Respiratory effects of non-tobacco cigarettes. Br. Med. J. 295, 1516–1518 (1987).
- Beshay M, Kaiser H, Niedhart D, Reymond M, Schmid R. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur. J. Cardio-Thorac. Surg. 32(6), 834–838 (2007).
- Reece AS. Cannabis as a cause of giant cystic lung disease. QJM 101(6), 503–503 (2008).
- Hii S, Tam DC, Thompson BR, Naughton MT. Bullous lung disease due to marijuana. Respirology 13, 122–127 (2007).
- Thompson CS. Lung bullae and marijuana. Thorax 57(6), 563–563 (2002).
- Johnson MK. Large lung bullae in marijuana smokers. Thorax 55(4), 340–342 (2000).
- Phan T, Lau K, Li X. Lung bullae and pulmonary fibrosis associated with marijuana smoking. Austalasian Radiol. 49, 411–414 (2005).
- Gill A. Bong lung: regular smokers of cannabis show relatively distinctive histologic changes that predispose to pneumothorax. Am. J. Surg. Pathol. 29, 980–982 (2005).
- Coffman K. The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects. Curr. Opin. Organ Transplant. 13, 189–195 (2008).
- Verweij PE. Fungal contamination of tobacco and marijuana. JAMA 284(22), 2875–2875 (2000).
- Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J. Allergy Clin. Immunol. 71(4), 389–393 (1983).
- Baldwin GC, Tashkin DP, Buckley DM, Park AN, Dubinett SM, Roth MD. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Resp. Crit. Care Med. 156, 1606–1613 (1997).
- Roth MD, Whittaker K, Salehi K, Baldwin GC. Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J. Neuroimmunol. 147, 82–86 (2004).
- Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J. Clin. Pharmacol. 42, 71S–81S (2002).
- Kaslow RA, Blackwelder WC, Ostrow DG et al. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the multicenter AIDS cohort study. JAMA 261(23), 3424–3429 (1989).
- Aldington S, Harwood M, Cox B et al. Cannabis use and risk of lung cancer: a case–control study. Eur. Respir. J. 31(2), 280–286 (2008).
- Berthiller J, Staif K, Boniol M et al. Cannabis smoking and risk of lung cancer in men. a pooled analysis of three studies in Maghreb. J. Thorac. Oncol. 3, 1398–1403 (2008).
- Brambilla C, Colonna M. Cannabis: the next villain on the lung cancer battlefield? Eur. Respir. J. 31(2), 227–228 (2008).
- Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch. Intern. Med. 166(13), 1359–1367 (2006).
- Hashibe M, Morgenstern H, Cui Y et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case–control study. Cancer Epidemiol. Biomarkers Prevent. 15(10), 1829–1834 (2006).
- Sewell RA, Cohn AJ, Chawarski MC. Doubts about the role of cannabis in causing lung cancer. Eur. Respir. J. 32(3), 815–816 (2008).
- Bagshaw SM, Hagen NA. Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature. J. Palliat. Care 18(2), 111–122 (2002).